-
公开(公告)号:EP2163537A4
公开(公告)日:2011-08-03
申请号:EP08740733
申请日:2008-04-21
申请人: TOYOTA MOTOR CO LTD
发明人: MATSUI MASAKI
IPC分类号: C07C69/24 , C07D307/26 , C07D307/33 , C07F5/02 , H01G11/54 , H01G11/60 , H01M10/052 , H01M10/0569 , H01M10/36
CPC分类号: C07F5/025 , C07C69/24 , C07D307/33 , C07F5/022 , H01G9/038 , H01G11/60 , H01M4/382 , H01M4/525 , H01M4/587 , H01M10/052 , H01M10/0525 , H01M10/056 , Y02E60/13
-
2.5-HETEROCYCLYLALKYL-3-HYDROXY-2-PHENYLCYCLOPENT-2-ENONES AS HERBICIDES 有权
标题翻译: 5-杂环基-3-羟基-2-苯基环戊-2-烯酮作为除草剂公开(公告)号:EP2313370A1
公开(公告)日:2011-04-27
申请号:EP09772473.6
申请日:2009-07-01
申请人: Syngenta Limited
发明人: JEANMART, Stephane, André, Marie , VINER, Russell , TAYLOR, John, Benjamin , WHITTINGHAM, William, Guy , WAILES, Jeffrey, Steven , TARGETT, Sarah , MATHEWS, Christopher, John , GOVENKAR, Mangala , CORDINGLEY, Matthew, Robert , RUSSELL, Claire, Janet , TYTE, Melloney
IPC分类号: C07D207/08 , C07D207/48 , C07D211/32 , C07D211/94 , C07D211/96 , C07D307/12 , C07D309/04 , C07D307/26 , C07D309/12 , C07D335/02 , C07D401/06 , C07D405/06 , C07D409/06 , C07D413/06 , C07D491/18
CPC分类号: C07D309/04 , A01N43/08 , A01N43/10 , A01N43/16 , A01N43/18 , A01N43/20 , A01N43/28 , A01N43/32 , A01N43/36 , A01N43/40 , A01N43/56 , A01N43/80 , A01N43/84 , A01N43/90 , A01N47/00 , A01N47/06 , A01N47/16 , A01N47/38 , A01N53/00 , A01N55/00 , C07D207/08 , C07D207/48 , C07D211/32 , C07D211/94 , C07D211/96 , C07D307/12 , C07D317/26 , C07D319/12 , C07D335/02 , C07D401/06 , C07D405/06 , C07D409/06 , C07D413/06 , C07D491/18 , C07F7/0812
摘要: Compounds of formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.
-
公开(公告)号:EP3548455A1
公开(公告)日:2019-10-09
申请号:EP17878682.8
申请日:2017-12-05
IPC分类号: C07B63/00 , C07D207/02 , C07D225/06 , C07D277/22 , C07D307/26 , C07D307/32 , C07D307/38 , C07D493/02 , C07H19/01 , B01D15/10 , B01J39/02 , B01J20/00
-
公开(公告)号:EP2054063A2
公开(公告)日:2009-05-06
申请号:EP07811504.5
申请日:2007-08-22
发明人: TUNG, Roger
IPC分类号: A61K31/517 , C07D239/94 , C07D307/26
CPC分类号: C07D405/04
摘要: This invention relates to novel 4-aminoquinazolines, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering inhibitors of the EGFR and HER-2.
-
5.PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO(2,3-b) FURAN-3-OL 有权
标题翻译: 制备(3α,3α/β,6α/ BETA)六氢呋喃并[2,3-b]呋喃-3-醇的立体异构体的公开(公告)号:EP1532127A1
公开(公告)日:2005-05-25
申请号:EP03762054.9
申请日:2003-06-25
发明人: DOAN, Brian, DanielGlaxoSmithKline , PATTERSON, Daniel, EdwardGlaxoSmithKline , ROBERTS, John, C.GlaxoSmithKline
IPC分类号: C07D307/26 , C07D493/04
CPC分类号: C07D493/04 , C07D307/26
摘要: The present invention provides processes and compounds that are useful in the preparation of (3α, 3aβ, 6aβ)-hexahydrofuro[2,3-b]furan-3-ol and diastereoisomers thereof, which are useful in the preparation of compounds that may be inhibitors of HIV aspartyl protease.
-
公开(公告)号:EP4444694A1
公开(公告)日:2024-10-16
申请号:EP22903439.2
申请日:2022-12-06
申请人: Peking University , Institute Of Genetics And Developmental Biology, Chinese Academy Of Sciences
发明人: LEI, Xiaoguang , ZHOU, Jian-Min , WANG, Haijun , MIAO, Pei , WANG, Wei
IPC分类号: C07C233/02 , C07C233/09 , C07D307/26 , C07C231/00 , A01N43/02 , A01N33/02
-
7.PREPARATION OF STEREOISOMERS OF (3ALPHA, 3ALPHA/BETA, 6ALPHA/BETA) HEXAHYDROFURO(2,3-b) FURAN-3-OL 有权
标题翻译: 的立体异构体制造(3α,3α/β,6α/ BETA)HEXAHYDROFURO¬2,3-B |呋喃-3-醇公开(公告)号:EP1532127B1
公开(公告)日:2006-09-27
申请号:EP03762054.9
申请日:2003-06-25
发明人: DOAN, Brian, Daniel GlaxoSmithKline , PATTERSON, Daniel, Edward GlaxoSmithKline , ROBERTS, John, C. GlaxoSmithKline
IPC分类号: C07D307/26 , C07D493/04
CPC分类号: C07D493/04 , C07D307/26
摘要: The present invention provides processes and compounds that are useful in the preparation of (3α, 3aβ, 6aβ)-hexahydrofuro[2,3-b]furan-3-ol and diastereoisomers thereof, which are useful in the preparation of compounds that may be inhibitors of HIV aspartyl protease.
-
公开(公告)号:EP1487269A4
公开(公告)日:2005-12-21
申请号:EP03714161
申请日:2003-03-13
申请人: UNIV MONTANA STATE
发明人: LIVINGHOUSE TOM
IPC分类号: C12N15/09 , A01N43/08 , A61K31/365 , A61P31/00 , A61P31/04 , C07D307/26 , C07D307/32 , C07D307/33 , C12N1/00 , A01N37/28 , A61K31/341 , C07D333/04
CPC分类号: C07D307/33 , C07D307/26 , C07D307/32
-
公开(公告)号:EP1487269A1
公开(公告)日:2004-12-22
申请号:EP03714161.1
申请日:2003-03-13
发明人: LIVINGHOUSE, Tom
IPC分类号: A01N43/08 , A01N37/28 , C07D307/26 , C07D333/04
CPC分类号: C07D307/33 , C07D307/26 , C07D307/32
摘要: Autoinducer compounds which enhance gene expression in a wide variety of microorganisms, therapeutic compositions and therapeutic methods wherein gene expression within microorganisms is regulated are disclosed.
-
10.INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES 审中-公开
标题翻译: 抑制剂氨基脲敏感性胺氧化酶(SSAO)和VAP-1介导的粘附,用于治疗和预防疾病的公开(公告)号:EP2004166A2
公开(公告)日:2008-12-24
申请号:EP07754673.7
申请日:2007-03-30
发明人: WANG, Eric, Y. , JONES, David, S. , O'ROURKE, Anne, M. , MACDONALD, Mary, T. , GAO, Hongfeng , TON-NU, Huong-thu , KESSLER, Christina, Ann , LINNIK, Matthew, D.
IPC分类号: A61K31/137 , A61K31/138 , A61K31/341 , A61K31/343 , A61K31/381 , A61K31/4402 , A61K31/4406 , A61K31/47 , C07C211/29 , C07D213/16 , C07D215/00 , C07D307/26 , C07D307/78 , C07D333/04 , C07D333/52
CPC分类号: C07C217/62 , A61K31/137 , A61K31/138 , A61K31/341 , A61K31/343 , A61K31/381 , A61K31/4402 , A61K31/4406 , A61K31/47 , C07C211/28 , C07C211/29 , C07C255/58 , C07C317/32 , C07C323/32 , C07C2601/02 , C07D213/38 , C07D213/65 , C07D215/12 , C07D307/52 , C07D307/81 , C07D333/20 , C07D333/28 , C07D333/58
摘要: Compositions and methods of using compositions for treatment of inflammatory diseases and immune disorders are provided. Allylamino compounds are disclosed which are inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein 1 (VAP-I). The compounds have therapeutic utility in suppressing inflammation and inflammatory responses, and in treatment of several disorders, including multiple sclerosis and stroke.
摘要翻译: 提供了组合物和使用组合物用于治疗炎性疾病和免疫病症的方法。 烯丙基化合物是游离缺失盘哪些是氨基脲敏感性胺氧化酶(SSAO)和/或血管粘附蛋白-1(VAP-1)的抑制剂。 的化合物具有抑制炎症和炎症反应的治疗效用,并在治疗几种疾病,包括多发性硬化和中风。
-
-
-
-
-
-
-
-
-